# Hemlibra

NDC: 50242-930
Generic name: emicizumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230316

FDA application: BLA761083

## Active ingredients

- EMICIZUMAB: 300 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-930"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-930
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2483adba-fab6-4d1b-96c5-c195577ed071